Literature DB >> 18413732

Broad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasms.

Xia Xu1, Jennifer L Page, Jennifer A Surtees, Houchun Liu, Sarah Lagedrost, Young Lu, Roderick Bronson, Eric Alani, Alexander Yu Nikitin, Robert S Weiss.   

Abstract

Ribonucleotide reductase (RNR) catalyzes the rate-limiting step in nucleotide biosynthesis and plays a central role in genome maintenance. Although a number of regulatory mechanisms govern RNR activity, the physiologic effect of RNR deregulation had not previously been examined in an animal model. We show here that overexpression of the small RNR subunit potently and selectively induces lung neoplasms in transgenic mice and is mutagenic in cultured cells. Combining RNR deregulation with defects in DNA mismatch repair, the cellular mutation correction system, synergistically increased RNR-induced mutagenesis and carcinogenesis. Moreover, the proto-oncogene K-ras was identified as a frequent mutational target in RNR-induced lung neoplasms. Together, these results show that RNR deregulation promotes lung carcinogenesis through a mutagenic mechanism and establish a new oncogenic activity for a key regulator of nucleotide metabolism. Importantly, RNR-induced lung neoplasms histopathologically resemble human papillary adenocarcinomas and arise stochastically via a mutagenic mechanism, making RNR transgenic mice a valuable model for lung cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18413732      PMCID: PMC2459241          DOI: 10.1158/0008-5472.CAN-07-5873

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

1.  S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs.

Authors:  S Björklund; S Skog; B Tribukait; L Thelander
Journal:  Biochemistry       Date:  1990-06-12       Impact factor: 3.162

Review 2.  Ribonucleotide reductases.

Authors:  Pär Nordlund; Peter Reichard
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

3.  Regulation of mammalian ribonucleotide reduction and dNTP pools after DNA damage and in resting cells.

Authors:  Pelle Håkansson; Anders Hofer; Lars Thelander
Journal:  J Biol Chem       Date:  2006-01-24       Impact factor: 5.157

4.  Suppression of lung tumor formation by the regulatory subunit of ribonucleotide reductase.

Authors:  Ashish Gautam; Gerold Bepler
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

Review 5.  DNA precursor metabolism and genomic stability.

Authors:  Christopher K Mathews
Journal:  FASEB J       Date:  2006-07       Impact factor: 5.191

Review 6.  Ribonucleotide reductase inhibitors and future drug design.

Authors:  J Shao; B Zhou; Bernard Chu; Y Yen
Journal:  Curr Cancer Drug Targets       Date:  2006-08       Impact factor: 3.428

7.  The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments.

Authors:  H Fan; A Huang; C Villegas; J A Wright
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

8.  Structurally dependent redox property of ribonucleotide reductase subunit p53R2.

Authors:  Lijun Xue; Bingsen Zhou; Xiyong Liu; Tieli Wang; Jennifer Shih; Christina Qi; Yvonne Heung; Yun Yen
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

9.  Detection of K-ras mutations in lung carcinomas: relationship to prognosis.

Authors:  P Keohavong; M A DeMichele; A C Melacrinos; R J Landreneau; R J Weyant; J M Siegfried
Journal:  Clin Cancer Res       Date:  1996-02       Impact factor: 12.531

Review 10.  Mechanisms in eukaryotic mismatch repair.

Authors:  Paul Modrich
Journal:  J Biol Chem       Date:  2006-08-11       Impact factor: 5.157

View more
  49 in total

1.  Endogenous DNA replication stress results in expansion of dNTP pools and a mutator phenotype.

Authors:  Marta B Davidson; Yuki Katou; Andrea Keszthelyi; Tina L Sing; Tian Xia; Jiongwen Ou; Jessica A Vaisica; Neroshan Thevakumaran; Lisette Marjavaara; Chad L Myers; Andrei Chabes; Katsuhiko Shirahige; Grant W Brown
Journal:  EMBO J       Date:  2012-01-10       Impact factor: 11.598

2.  Multiphoton microscopy as a diagnostic imaging modality for lung cancer.

Authors:  Ina Pavlova; Kelly R Hume; Stephanie A Yazinski; Rachel M Peters; Robert S Weiss; Watt W Webb
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2010-01-24

Review 3.  Metabolic genes in cancer: their roles in tumor progression and clinical implications.

Authors:  Eiji Furuta; Hiroshi Okuda; Aya Kobayashi; Kounosuke Watabe
Journal:  Biochim Biophys Acta       Date:  2010-02-01

4.  Dynamic Control of dNTP Synthesis in Early Embryos.

Authors:  Yonghyun Song; Robert A Marmion; Junyoung O Park; Debopriyo Biswas; Joshua D Rabinowitz; Stanislav Y Shvartsman
Journal:  Dev Cell       Date:  2017-07-20       Impact factor: 12.270

5.  Multiple factors insulate Msh2-Msh6 mismatch repair activity from defects in Msh2 domain I.

Authors:  Charanya Kumar; Sarah C Piacente; Justin Sibert; Andrew R Bukata; Jaime O'Connor; Eric Alani; Jennifer A Surtees
Journal:  J Mol Biol       Date:  2011-06-25       Impact factor: 5.469

6.  p53R2 expression as a prognostic biomarker in early stage non-small cell lung cancer.

Authors:  Nan-Yung Hsu; Jeng-Yuan Wu; Xiyong Liu; Yun Yen; Chih-Yi Chen; Ming-Chih Chou; Huei Lee; Ya-Wen Cheng
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

Review 7.  Deoxyribonucleotide metabolism, mutagenesis and cancer.

Authors:  Christopher K Mathews
Journal:  Nat Rev Cancer       Date:  2015-09       Impact factor: 60.716

8.  AAV6-mediated Cardiac-specific Overexpression of Ribonucleotide Reductase Enhances Myocardial Contractility.

Authors:  Stephen C Kolwicz; Guy L Odom; Sarah G Nowakowski; Farid Moussavi-Harami; Xiaolan Chen; Hans Reinecke; Stephen D Hauschka; Charles E Murry; Gregory G Mahairas; Michael Regnier
Journal:  Mol Ther       Date:  2015-09-21       Impact factor: 11.454

9.  Transgenic overexpression of ribonucleotide reductase improves cardiac performance.

Authors:  Sarah G Nowakowski; Stephen C Kolwicz; Frederick Steven Korte; Zhaoxiong Luo; Jacqueline N Robinson-Hamm; Jennifer L Page; Frank Brozovich; Robert S Weiss; Rong Tian; Charles E Murry; Michael Regnier
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

10.  Bcl2 induces DNA replication stress by inhibiting ribonucleotide reductase.

Authors:  Maohua Xie; Yun Yen; Taofeek K Owonikoko; Suresh S Ramalingam; Fadlo R Khuri; Walter J Curran; Paul W Doetsch; Xingming Deng
Journal:  Cancer Res       Date:  2013-11-06       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.